What's in the pipeline?
D000818:Animals; D000991:Antithrombins / Q000627:therapeutic use*; D001709:Biotechnology; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D001861:Bone Regeneration; D016025:Bone Transplantation; D002986:Clinical Trials as Topic; D004260:DNA Repair; D043224:Deoxyribonuclease (Pyrimidine Dimer); D004337:Drug Carriers; D004706:Endodeoxyribonucleases / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005599:Fractures, Ununited / Q000628:therapy; D024764:Hirudin Therapy; D006801:Humans; D008081:Liposomes; D009824:Ointments; D011323:Primates; D011506:Proteins / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D016212:Transforming Growth Factor beta; D014983:Xeroderma Pigmentosum / Q000188:drug therapy*
D000991:Antithrombins; C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D004337:Drug Carriers; D005343:Fibrinolytic Agents; D008081:Liposomes; D009824:Ointments; D011506:Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D004706:Endodeoxyribonucleases; D043224:Deoxyribonuclease (Pyrimidine Dimer)